At a glance
- Originator IVAX Pharmaceuticals UK; Nonindustrial source
- Class
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Epilepsy; Parkinson's disease; Stroke
Most Recent Events
- 05 Jan 2004 No development reported - Preclinical for Parkinson's disease in Hungary (unspecified route)
- 08 May 2000 New profile
- 08 May 2000 Preclinical development for Epilepsy in Hungary (Unknown route)